The recipient was a 57-year-old terminally ill man who received a heart from a gene-modified pig. After retrieval, the pig heart was preserved with XVIVO's heart perfusion device and proprietary ...

non-ischemic perfusion. In 2022, XVIVO´s heart technology was featured in the global news as a crucial component for the success of the first xeno (pig to human) heart transplant that was ...

"We like to think that we're removing the impact of time by using machine perfusion." Dr. Granger said the technology represents a true sea change for heart transplant teams. "When I began my ...

GOTHENBURG, SWEDEN / ACCESSWIRE / January 10, 2022 / XVIVO Perfusion AB (STO ... Groundbreaking research, utilizing XVIVOs heart preservation technology, has in recent years achieved long-term ...